UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European journal of pharmacology, ISSN 0014-2999, 04/2009, Volume 607, Issue 1-3, p. 151
Journal Article
Talanta (Oxford), ISSN 0039-9140, 03/2008, Volume 75, Issue 1, p. 63
Journal Article
Annals of emergency medicine, ISSN 0196-0644, 2016, Volume 68, Issue 4, pp. S50 - S50
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2004, Volume 170, Issue 8, pp. 836 - 844
Antiasthmatic agents | Salmeterol | Fluticasone propionate | Guidelines | Quality of life | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care | Biological and medical sciences | Intensive care medicine | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Bronchodilator Agents - therapeutic use | Prospective Studies | Asthma - prevention & control | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | Dose-Response Relationship, Drug | Time Factors | Albuterol - administration & dosage | Adult | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Salmeterol Xinafoate | Double-Blind Method | Albuterol - analogs & derivatives | Treatment Outcome | Asthma - drug therapy | Androstadienes - administration & dosage | Quality of Life | Albuterol - therapeutic use | Androstadienes - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus
Journal Article
Molecular genetics and metabolism, ISSN 1096-7192, 01/2017, Volume 120, Issue 1-2, pp. S142 - S142
Journal Article
Annals of emergency medicine, ISSN 0196-0644, 2015, Volume 66, Issue 4, pp. S136 - S136
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2011, Volume 128, Issue 2, pp. 315 - 322
Allergy and Immunology | airway obstruction | agonist receptor | bronchodilators | Arginine/arginine genotype | muscarinic receptor | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Male | Arginine - genetics | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Asthma - physiopathology | Double-Blind Method | Receptors, Adrenergic, beta-2 - genetics | Administration, Inhalation | Albuterol - analogs & derivatives | Genotype | Treatment Outcome | Asthma - drug therapy | Asthma - genetics | Polymorphism, Single Nucleotide - genetics | Albuterol - therapeutic use | Respiratory Function Tests | Peak Expiratory Flow Rate | Albuterol - adverse effects | Antiasthmatic agents | Corticosteroids | Asthma | Studies | Chronic obstructive pulmonary disease | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 06/2011, Volume 337, Issue 3, pp. 600 - 609
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Adrenergic beta-2 Receptor Agonists - pharmacokinetics | Ethanolamines - pharmacology | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Albuterol - pharmacology | Humans | Half-Life | Pulmonary Disease, Chronic Obstructive - physiopathology | Ethanolamines - administration & dosage | Adrenergic beta-2 Receptor Agonists - pharmacology | Bronchodilator Agents - chemistry | Ethanolamines - pharmacokinetics | Benzoxazines - pharmacokinetics | Albuterol - administration & dosage | Binding Sites | Benzoxazines - chemistry | Cricetinae | Salmeterol Xinafoate | Benzoxazines - administration & dosage | Adrenergic beta-2 Receptor Agonists - chemistry | Administration, Inhalation | Albuterol - analogs & derivatives | Albuterol - pharmacokinetics | Bronchodilator Agents - pharmacology | Receptors, Adrenergic, beta-1 - metabolism | Ethanolamines - chemistry | Asthma - drug therapy | Receptors, Adrenergic, beta-2 - metabolism | Animals | Bronchodilator Agents - pharmacokinetics | Benzoxazines - pharmacology | Adrenergic beta-2 Receptor Agonists - administration & dosage | Albuterol - chemistry | Mice | Mice, Inbred BALB C | Lipid Bilayers - metabolism | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Nature (London), ISSN 0028-0836, 01/2011, Volume 469, Issue 7329, pp. 241 - 244
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Dobutamine - metabolism | Hydroxyquinolines - chemistry | Catecholamines - metabolism | Albuterol - pharmacology | Amphetamines - pharmacology | Adrenergic beta-1 Receptor Antagonists - pharmacology | Crystallography, X-Ray | Adrenergic beta-1 Receptor Agonists - chemistry | Structure-Activity Relationship | Receptors, Adrenergic, beta-1 - chemistry | Adrenergic beta-1 Receptor Agonists - pharmacology | Turkeys | Adrenergic beta-1 Receptor Antagonists - chemistry | Drug Design | Adrenergic beta-1 Receptor Antagonists - metabolism | Dobutamine - chemistry | Isoproterenol - chemistry | Binding Sites | Hydroxyquinolines - pharmacology | Amphetamines - chemistry | Drug Partial Agonism | Albuterol - metabolism | Hydroxyquinolines - metabolism | Isoproterenol - metabolism | Models, Molecular | Receptors, Adrenergic, beta-1 - metabolism | Serine - chemistry | Serine - metabolism | Dobutamine - pharmacology | Animals | Hydrogen Bonding | Amphetamines - metabolism | Isoproterenol - pharmacology | Protein Stability - drug effects | Albuterol - chemistry | Ligands | Protein Conformation | Adrenergic beta-1 Receptor Agonists - metabolism | Index Medicus
Journal Article
Chest, ISSN 0012-3692, 12/2009, Volume 136, Issue 6, pp. 1456 - 1465
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Osteoporosis. Osteomalacia. Paget disease | Diseases of the osteoarticular system | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Bone Diseases, Metabolic - epidemiology | Prevalence | Prospective Studies | Albuterol - pharmacology | United States | Humans | Middle Aged | Fractures, Bone - epidemiology | Male | Fluticasone | Bone Diseases, Metabolic - complications | Female | Bronchodilator Agents - adverse effects | Osteoporosis - epidemiology | Salmeterol Xinafoate | Osteoporosis - chemically induced | Double-Blind Method | Risk Factors | Albuterol - analogs & derivatives | Bronchodilator Agents - pharmacology | Treatment Outcome | Pulmonary Disease, Chronic Obstructive - complications | Bone Diseases, Metabolic - chemically induced | Disease Progression | Bone Density - drug effects | Androstadienes - pharmacology | Osteoporosis - complications | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Fluticasone-Salmeterol Drug Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Osteoporosis | Complications and side effects | Development and progression | Lung diseases, Obstructive | Corticosteroids | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2007, Volume 175, Issue 2, pp. 144 - 149
Exacerbation | Combination treatment | Chronic obstructive pulmonary disease | Inhaled corticosteroids | agonists | Long-acting β | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Salmeterol Xinafoate | Bronchodilator Agents - administration & dosage | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Albuterol - analogs & derivatives | Male | Fluticasone | Androstadienes - administration & dosage | Lung - drug effects | Albuterol - administration & dosage | Quality of Life | Albuterol - therapeutic use | Female | Aged | Androstadienes - therapeutic use | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 03/2011, Volume 139, Issue 3, pp. 505 - 512
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | C-Reactive Protein - metabolism | Pneumonia - mortality | Pneumonia - chemically induced | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Double-Blind Method | Pneumonia - epidemiology | Risk Factors | Kaplan-Meier Estimate | Administration, Inhalation | Albuterol - analogs & derivatives | Pulmonary Disease, Chronic Obstructive - complications | Adrenal Cortex Hormones - adverse effects | Androstadienes - administration & dosage | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Usage | Pneumonia | Corticosteroids | Bacterial pneumonia | Research | Index Medicus | Abridged Index Medicus
Journal Article
Water research (Oxford), ISSN 0043-1354, 10/2017, Volume 123, p. 715
Journal Article
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, ISSN 1570-0232, 05/2018, Volume 1084, p. 64
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, pp. 1093 - 1103
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Prevention and actions | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Glucocorticoids - therapeutic use | Humans | Middle Aged | Male | Adrenergic beta-2 Receptor Agonists - adverse effects | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Cholinergic Antagonists - adverse effects | Scopolamine Derivatives - therapeutic use | Cholinergic Antagonists - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Double-Blind Method | Pneumonia - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Administration, Inhalation | Albuterol - analogs & derivatives | Pulmonary Disease, Chronic Obstructive - prevention & control | Albuterol - therapeutic use | Aged | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Prevention | Tiotropium | Lung diseases, Obstructive | Salmeterol | Causes of | Comparative analysis | Drug therapy | Chronic obstructive pulmonary disease | Statistical analysis | Pharmaceutical industry | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Analytical biochemistry, ISSN 0003-2697, 2011, Volume 419, Issue 2, pp. 76 - 80
Fluorescence spectroscopy | Voltammetry | Salbutamol | MCR–ALS | DNA | MCR-ALS | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Multivariate Analysis | Oxidation-Reduction | Humans | Spectrometry, Fluorescence | Glass - chemistry | Carbon - chemistry | Albuterol - analysis | Electrodes | DNA - chemistry | Animals | Cattle | Least-Squares Analysis | Albuterol - chemistry | Albuterol - urine | Electrochemical Techniques - methods | Albuterol - blood | Hydrogen-Ion Concentration | Genetic research | Fluorescence | Antiasthmatic agents | Albuterol | Index Medicus
Journal Article